Amen Clinics Washington D.C. to Offer IV Nutrient Therapy and Other Functional Medicine Services
RESTON, Va., Nov. 5, 2019 /PRNewswire/ -- Amen Clinics Washington, D.C. is now offering several different types of intravenous therapies such as IV Nutrient Therapy as well as other functional medicine services. These can range from immune system enhancement to detoxification and relaxation and have been proven to be beneficial for overcoming many conditions.
One of the main benefits of intravenous treatment is that nutrients are infused directly into the bloodstream. Intravenous treatments (IV therapy) therefore are exceptionally powerful because they circumvent issues with oral administration, including stomach upset, absorption issues, and loss of potency.
Integrative physician, Dr. Eboni Cornish states, "In functional medicine we determine the root causes of your current symptoms - the causes of toxic brain scans can be more biological than psychiatric and as a result we have to determine the root cause."
IV therapies have been known to be beneficial for the following conditions:
ABOUT AMEN CLINICS Amen Clinics, Inc. was established in 1989 by Daniel G. Amen, MD, who is a psychiatrist, neuroscientist, and 10-time New York Times bestselling author. Amen Clinics has the world's largest database of functional brain scans relating to behavior, totaling over 160,000 scans on patients from 121 countries.
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...
Product: Meat and vegetable products
Issue: Food - Microbial Contamination - Listeria
Distribution:British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...